2020 Spring Grants Announced
This past Spring, CRF funded 10 new grants, 4 research grant extensions, and
1 lab equipment grant, totaling more than $2,629,490 for cystinosis research. And since 2003, CRF has funded 200 multi-year grants in 12 countries which has made CRF the largest funder of cystinosis research in the world. Thank you to everyone who has supported and contributed to CRF over the years – every single penny has helped make a cure for cystinosis possible. Together, we shine bright!
GRANT AWARDS
Sergio Catz, PhD, Research Mentor
Raquel Carvalho Gontijo, PhD, Research Fellow
The Scripps Research Institute, La Jolla, California
“Novel Mechanistic and Translational Studies of Neutrophil-Mediated
Inflammation in Cystinosis”
$150,000.00 – Two-year study
Sergio Catz, PhD, Research Mentor
Farhana Rahman, PhD, Research Fellow
The Scripps Research Institute, La Jolla, California
“Molecular Trafficking Regulators of Dynamic Organelles in Cystinosis”
$150,000.00 – Two-year study
Pierre Courtoy, MD, PhD, Principal Investigator
Christophe Pierreux, PhD, Co-Principal Investigator
de Duve Institute, Louvain University Medical School
Brussels, Belgium ($5,500)
Laura Rega, PhD, Principal Investigator
Ospedale Pediatrico Bambino Gesù, Rome, Italy ($37,301)
“Secondary Treatment of Ctns -/- Rats by Oral Dibasic Amino-Acids, with Focus on Fanconi Syndrome”
$42,801.00 – Six-month study
Shawn Davidson, PhD, Principal Investigator
Princeton University, Princeton, New Jersey
“Metabolomics of Hematopoietic Stem Cell Therapy in Ctns -/- Mice”
$160,244 – One-year study
Olivier Devuyst, MD, PhD, Principal Investigator
Alessandro Luciani, PhD, Co-Principal Investigator
University of Zürich, Zürich, Switzerland
“New Model Systems for Integrated Drug Discovery in Cystinosis”
$290,000. 00 – Two-year study
Morgan Fedorchak, PhD, Principal Investigator
Kanwal Nichal, MD, FRCO, Co-Principal Investigator
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
“Development of a Topical Controlled Release Cysteamine Eye Drop”
$410,810.00 – Two-year study
Liang Feng, PhD, Research Mentor
Xue Guo, PhD, Research Fellow
Stanford University, Stanford, California
“Molecular Mechanisms of Cystinosis”
$150,000.00 – Two-year study
Jennifer Hollywood, PhD, Principal Investigator
Alan Davidson, PhD, Co-Principal Investigator
University of Auckland, New Zealand
“A Pre-Clinical Drug Study Using Cysteamine/Everolimus Combination Therapy to Treat Cystinosis Knock-Out Rats”
$200,530.00 – Two-year study
Sophie Molholm, PhD, Principal Investigator
John Foxe, PhD, Co-Principal Investigator
Albert Einstein College of Medicine, Bronx, New York
“The Development of Neuromarkers of Cognitive Disfunction in Cystinosis”
$333,164.00 – Two-year study
Michael Sekar, PhD, Principal Investigator
Laura Rega, PhD, Co-Principal Investigator
Amma Therapeutics, Inc., Hayward, California
“Development of a Once-Daily Subcutaneous Injection of Cysteamine Bitartrate”
$304,064.00 – One-year study
Grant Extensions
Corinne Antignac, MD, PhD, Principal Investigator
IMAGINE Institute, Paris, France
“Intra-Dermal Imaging of Subjects with Cystinosis Using Confocal Microscopy”
$31,306.00 – One-year extension
Stéphanie Cherqui, PhD, Principal Investigator
University of California, San Diego, La Jolla, California
“Intra-Dermal Imaging of Subjects with Cystinosis Using Confocal Microscopy”
$102,755.00 – One-year extension
Olivier Devuyst, MD, PhD, Principal Investigator
University of Zürich, Zürich, Switzerland
“Development and Characterization of a Rat Model of Cystinosis”
$115,500.00 – One-year extension
Francesco Emma, MD, Principal Investigator
Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
“Development and Characterization of a Rat Model of Cystinosis”
$105,996.00 – One-year extension
Equipment Grant
Stéphanie Cherqui, PhD
University of California, San Diego, La Jolla, California
HRT3-RCM
$82,320.00 – Purchase Total
